Revive Longevity review

The tirzepatide product price is visible, but it is not a confirmed all-in bill until Revive clarifies whether a membership is mandatory and which labs or other charges apply.

Revive Longevity LLC operates the site and platform. Its terms identify Telegra MD and affiliates as a clinical network and Strive Pharmacy in Arizona as a fulfillment partner. These disclosures do not identify the clinician or pharmacy for a particular order.

The site describes clinician review, follow-up as appropriate, medication if prescribed and free standard shipping. The product page lists BMI criteria of 30 or greater, or 27 or greater with a weight-related condition, subject to clinical judgment. First public order landing shows no cost. The site claims all-state care in places, but its shipping policy says availability varies by state. Standalone tirzepatide lab requirements and charges are not clear; the separate membership tiers have different blood-panel inclusions.

The tirzepatide product page shows $279 every four weeks by subscription, $299 for a one-time one-month supply, or $749 prepaid for three months. A separate pricing page lists Foundation at $299, Core at $599 and Private at $999 every four weeks, with different product and lab inclusions. The public pages do not say clearly whether a tirzepatide buyer must also purchase one of those memberships. Do not add the amounts together or treat a membership price as the medication price without a written selected-order quote. Revive says it does not accept insurance.

The product page describes card authorization at checkout and no final charge until clinician approval; terms say the full selected supply period is due at checkout, with authorization finalized after approval. The refund policy says a pending authorization is released and no treatment charge follows if a clinician does not approve treatment. The same policy says a completed medical consultation fee is nonrefundable even if no prescription is issued; it does not explain whether that separate fee applies to this product order. Future renewals can be canceled before they process, current processed periods are nonrefundable, and early cancellation after review may incur up to $50. Confirm the first debit, any consultation fee, renewal date and exit charge before ordering.

The current product page describes compounded tirzepatide by weekly injection, subject to clinician approval. The chosen dose, vial quantity, refill schedule and assigned pharmacy are not publicly established. Revive says the compounded preparation is not FDA-approved. Its stated shipment in one to two days after approval describes dispatch; the shipping policy estimates delivery in five to ten business days.